| For: | Gao T, Zhong KP, Wang JZ, Chen Y, Li CX. Allyl isothiocyanate ameliorates metabolic dysfunction-associated steatotic liver disease via vitamin D receptors in hepatocytes. World J Gastroenterol 2026; 32(4): 113647 [PMID: 41640867 DOI: 10.3748/wjg.v32.i4.113647] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v32/i4/113647.htm |
| Number | Citing Articles |
| 1 |
Shang-Ming Liu, Peng Zhang, Chun Guo, Ming Liu. Letter to the Editor: Unveiling a novel vitamin D receptor signaling pathway for allyl isothiocyanate against metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology 2026; 32(16): 116951 doi: 10.3748/wjg.v32.i16.116951
|
| 2 |
Héctor Fuentes-Barría, Raúl Aguilera-Eguía, Miguel Alarcón-Rivera, Cherie Flores-Fernández. Vitamin D and Metabolic Syndrome: Molecular Mechanisms and Clinical Implications: A Narrative Review. International Journal of Molecular Sciences 2026; 27(16) doi: 10.3390/ijms27167101
|
| 3 |
Teng-Fei Liu, Guang-Yu Yao, Qing-Qing Zhou. From dinner table to liver: Allyl isothiocyanate aids metabolic dysfunction-associated steatotic liver disease treatment. World Journal of Gastroenterology 2026; 32(32): 117348 doi: 10.3748/wjg.117348
|
| 4 |
Ce-Fan Zhou, Jing-Feng Tang, Xing-Zhen Chen, Jie-Yu Guo, Yi-Xin Wu, Rui Tian. Letter to the Editor: Natural product intervention in metabolic dysfunction-associated steatotic liver disease: From allyl isothiocyanate to signaling networks. World Journal of Hepatology 2026; 18(8): 117382 doi: 10.4254/wjh.117382
|